Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1318-1323

  Cirioni, Oscar ^a   Ghiselli, Roberto ^a   Silvestri, Carmela ^a   Minardi, Daniele ^a   Gabrielli, Eleonora ^a   Orlando, Fiorenza ^b   Rimini, Massimiliano ^a   Brescini, Lucia ^a   Muzzonigro, Giovanni ^a   Guerrieri, Mario ^a   Giacometti, Andrea ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

Author keywords

Antibiotics; Bacterial biofilm; Medical devices; Quorum sensing

Indexed keywords

AMIKACIN; CLARITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BIOFILM; CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; EVALUATION; FEMALE; IMPLANT; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PROSTHESIS INFECTION; PSEUDOMONAS AERUGINOSA; RAT; URETER STENT INFECTION;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CLARITHROMYCIN; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, WISTAR; STENTS; URETERAL DISEASES;

EID: 79956005311     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr107     Document Type: Article

References (40)

1. Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 2008; 5: 598-608.
2. Tenke P, Kovacs B, Jäckel M, et al. The role of biofilm infection in urology. World J Urol 2006; 24: 13-20.
3. Koeijers JJ, Verbon A, Kessels AG, et al. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 2010; 76: 336-40.
4. Beiko DT, Knudsen BE, Watterson JD, et al. Urinary tract biomaterials. J Urol 2004; 171: 2438-44.
5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilm: a common cause of persistent infections. Science 1999; 284: 1318-22.
6. Vlastarakos PV, Nikolopoulos TP, Maragoudakis P, et al. Biofilms in ear, nose, and throat infections: how important are they? Laryngoscope 2007; 117: 668-73.
7. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
8. Fux CA, Costerton JW, Stewart PS, et al. Survival strategies of infectious biofilm. Trends Microbiol 2005; 13: 34-40.
9. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-9.
10. Stewart PS, Costerton JW. Antibiotic resistance of bacteria biofilm. Lancet 2001; 358: 135-8.
11. Coenye T, Nelis HJ. In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods 2010; 83: 89-105.
12. Le Berre R, Nguyen S, Nowak E, et al. Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008; 14: 337-43.
13. Kerr KG, Snelling AM. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009; 73: 338-44.
14. Tateda K, Comte R, Pechere J-C, et al. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001; 45: 1930-3.
15. Tre'-Hardy M, Vanderbist F, Traore H, et al. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Int J Antimicrob Agents 2008; 31: 329-36.
16. Abdi-Ali A, Mohammadi-Mehrb M, Agha Alaei Y. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents 2006; 27: 196-200.
17. Fonseca AP, Sousa JC. Effect of antibiotic-induced morphological changes on surface properties, motility and adhesion of nosocomial Pseudomonas aeruginosa strains under different physiological states. J Appl Microbiol 2007; 103: 1828-37.
18. Pearson JP, Gray KM, Passador L, et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci USA 1994; 91: 197-201.
19. Pearson JP, Passador L, Iglewski BH, et al. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1995; 92: 1490-4.
20. Geisenberger O, Givskov M, Riedel K, et al. Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis. FEMS Microbiol Lett 2000; 184: 273-8.
21. Kawamura-Sato K, Iinuma Y, Hasegawa T, et al. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrob Agents Chemother 2000; 44: 2869-72.
22. Li Y, Xie YY, Chen RX, et al. Effects of combined treatment with sansamycin and macrolides on Pseudomonas aeruginosa and formation of biofilm. Biomed Environ Sci 2009; 22: 170-7.
23. Kandemir O, Oztuna V, Milcan A, et al. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clin Orthop Relat Res 2005; 430: 171-5.
24. Garraffo R, Drugeon HB, Dellamonica P, et al. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother 1990; 34: 614-21.
25. Chu SY, Wilson DS, Guay DR, et al. Clarithromycin pharmacokinetics in healthy young and elderly volunteers. J Clin Pharmacol 1992; 32: 1045-9.
26. Stepanovic S, Vukovic D, Dakic I, et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000; 40: 175-9.
27. Cirioni O, Giacometti A, Ghiselli R, et al. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides 2006; 27: 1210-6.
28. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
29. Eliopoulos GM, Moellering RC Jr. Antimicrobial combinations. In: Lorian V, ed. Antibiotics in Laboratory Medicine. Baltimore: Williams & Wilkins, 1996; 330-93.
30. Barros M, Martinelli R, Rocha H. Experimental supratrigonal cystectomy. Evaluation of long term complications. Int Braz J Urol 2006; 32: 350-4.
31. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004;2: 95-108.
32. Keane PF, Bonner MC, Johnston SR, et al. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol 1994; 73: 687-91.
33. Hachem R, Reitzel R, Borne A, et al. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 2009; 53: 5145-9.
34. Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit Care Med 2010; 38 Suppl 8: S373-9.
35. Howe RA, Spencer RC. Macrolides for treatment of Pseudomonas aeruginosa infections? J Antimicrob Chemother 1997; 40: 153-5.
36. Tanaka G, Shigeta M, Komatsuzawa H, et al. Effect of clarithromycin on Pseudomonas aeruginosa biofilm. Chemotherapy 2000; 46: 36-42.
37. Tre'-Hardy M, Nagant C, El Manssouri N, et al. Efficacy of the combination of tobramycin and a macrolides in an in vitro Pseudomonas aeruginosa mature biofilm model. Antimicrob Agents Chemother 2010; 54: 4409-15.
38. Furuhata M, Iwamura M, Baba S, et al. Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty. Int J Urol 2003; 10: 228-30.
39. Hoffmann N, Lee B, Hentzer M, et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr2/2 mice. Antimicrob Agents Chemother 2007; 51: 3677-87.
40. Yasuda H, Ajiki Y, Koga T, et al. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993; 37: 1749-55.